Phio Pharmaceuticals to present PH-762 clinical update at Life Sciences Future Conference

Bitget2026/09/23 11:06

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Phio Pharmaceuticals will present at the Life Sciences Future 2026 Conference on September 30 to October 1, 2026.
Management plans a clinical development update on PH-762 following its completed Phase 1b study in cutaneous squamous cell carcinoma.
The talk is scheduled for September 30, 2026 at 10:20 a.m. ET in King of Prussia, Pennsylvania.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609230700NEWSFILECNPR____20260923_315517_1) on September 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Phio Pharmaceuticals to present PH-762 clinical update at Life Sciences Future Conference

You may also like

Crypto prices